{ "cik": 1069899, "cik_padded": "0001069899", "entityName": "PHIBRO ANIMAL HEALTH CORP", "fiscal_years": [ { "accn": "0001558370-25-011776", "filed": "2025-08-27", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 38293000.0, "cash": 68039000.0, "cost_of_revenue": 896273000.0, "dividends_paid": 19449000.0, "eps_diluted": 1.19, "free_cash_flow": 41831000.0, "gross_profit": 399942000.0, "net_income": 48264000.0, "operating_cash_flow": 80124000.0, "operating_income": 110465000.0, "revenue": 1296215000.0, "stockholders_equity": 285682000.0, "total_assets": 1360900000.0, "total_liabilities": 1075218000.0 }, "period_end": "2025-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.30854603595854085, "leverage": 3.763688296777536, "net_margin": 0.037234563710495557, "operating_margin": 0.08522120172965134, "payout_ratio": 0.4029711586275485, "revenue_growth_yoy": 0.27369730533891334, "roa_avg2y": 0.04119698653569398, "roa_period_end": 0.03546476596370049, "roe_avg2y": 0.1779898695058111, "roe_period_end": 0.16894309056923432 } }, { "accn": "0001558370-25-011776", "filed": "2025-08-27", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 41238000.0, "cash": 70613000.0, "cost_of_revenue": 704587000.0, "dividends_paid": 19442000.0, "eps_diluted": 0.06, "free_cash_flow": 46356000.0, "gross_profit": 313092000.0, "net_income": 2416000.0, "operating_cash_flow": 87594000.0, "operating_income": 53315000.0, "revenue": 1017679000.0, "stockholders_equity": 256641000.0, "total_assets": 982184000.0, "total_liabilities": 725543000.0 }, "period_end": "2024-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.30765300256760725, "leverage": 2.8270736164525543, "net_margin": 0.0023740295319054435, "operating_margin": 0.05238881808507398, "payout_ratio": 8.047185430463577, "revenue_growth_yoy": 0.04068968972961144, "roa_avg2y": 0.002473406528830901, "roa_period_end": 0.002459824228454139, "roe_avg2y": 0.008962255402021701, "roe_period_end": 0.009413928405827596 } }, { "accn": "0001558370-25-011776", "filed": "2025-08-27", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 51794000.0, "cash": 41281000.0, "cost_of_revenue": 679652000.0, "dividends_paid": 19442000.0, "eps_diluted": 0.81, "free_cash_flow": -38484000.0, "gross_profit": 298237000.0, "net_income": 32606000.0, "operating_cash_flow": 13310000.0, "operating_income": 71847000.0, "revenue": 977889000.0, "stockholders_equity": 282509000.0, "total_assets": 971397000.0, "total_liabilities": 688888000.0 }, "period_end": "2023-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.30498042211334825, "leverage": 2.438463907344545, "net_margin": 0.03334325265955543, "operating_margin": 0.0734715289772152, "payout_ratio": 0.5962706250383365, "revenue_growth_yoy": 0.037811179704986195, "roa_avg2y": 0.034266269279111514, "roa_period_end": 0.03356609089795418, "roe_avg2y": 0.11966580481547882, "roe_period_end": 0.1154157920632617 } }, { "accn": "0001558370-24-012517", "filed": "2024-08-28", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 37044000.0, "cash": 74248000.0, "cost_of_revenue": 656861000.0, "dividends_paid": 19442000.0, "eps_diluted": 1.21, "free_cash_flow": -5395000.0, "gross_profit": 285400000.0, "net_income": 49175000.0, "operating_cash_flow": 31649000.0, "operating_income": 78986000.0, "revenue": 942261000.0, "stockholders_equity": 262442000.0, "total_assets": 931699000.0, "total_liabilities": 669257000.0 }, "period_end": "2022-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.302888477820901, "leverage": 2.5501139299349953, "net_margin": 0.052188300269245994, "operating_margin": 0.08382603121640395, "payout_ratio": 0.39536349771225215, "revenue_growth_yoy": 0.13069058618827623, "roa_avg2y": 0.05547020232100637, "roa_period_end": 0.05277992141238748, "roe_avg2y": 0.19631874898946247, "roe_period_end": 0.1873747342269911 } }, { "accn": "0001558370-23-015357", "filed": "2023-08-30", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 29320000.0, "cash": 50212000.0, "cost_of_revenue": 561973000.0, "dividends_paid": 19430000.0, "eps_diluted": 1.34, "free_cash_flow": 18986000.0, "gross_profit": 271377000.0, "net_income": 54385000.0, "operating_cash_flow": 48306000.0, "operating_income": 74868000.0, "revenue": 833350000.0, "stockholders_equity": 238529000.0, "total_assets": 841325000.0, "total_liabilities": 602796000.0 }, "period_end": "2021-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.32564588708225833, "leverage": 2.5271392577003216, "net_margin": 0.06526069478610427, "operating_margin": 0.08983980320393592, "payout_ratio": 0.3572676289418038, "revenue_growth_yoy": 0.04122675715995672, "roa_avg2y": 0.06691788301521141, "roa_period_end": 0.06464208242950109, "roe_avg2y": 0.2548900600609749, "roe_period_end": 0.22800162663659346 } }, { "accn": "0001558370-22-013940", "filed": "2022-08-24", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 34045000.0, "cash": 36343000.0, "cost_of_revenue": 543472000.0, "dividends_paid": 19418000.0, "eps_diluted": 0.83, "free_cash_flow": 25303000.0, "gross_profit": 256882000.0, "net_income": 33552000.0, "operating_cash_flow": 59348000.0, "operating_income": 69194000.0, "revenue": 800354000.0, "stockholders_equity": 188204000.0, "total_assets": 784100000.0, "total_liabilities": 595896000.0 }, "period_end": "2020-06-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.320960474989817, "leverage": 3.166223884720835, "net_margin": 0.04192144975848187, "operating_margin": 0.08645424399703132, "payout_ratio": 0.5787434430138293, "roa_avg2y": 0.044417055927073, "roa_period_end": 0.04279046040045913, "roe_avg2y": 0.16600901986299507, "roe_period_end": 0.1782746381585939 } }, { "accn": "0001558370-22-013940", "filed": "2022-08-24", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 29891000.0, "cash": 57573000.0, "eps_diluted": 1.35, "free_cash_flow": 17278000.0, "gross_profit": 264624000.0, "net_income": 54713000.0, "operating_cash_flow": 47169000.0, "operating_income": 83226000.0, "stockholders_equity": 216015000.0, "total_assets": 726671000.0, "total_liabilities": 510656000.0 }, "period_end": "2019-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.363983982593801, "roa_avg2y": 0.07825365609468302, "roa_period_end": 0.07529267027306717, "roe_avg2y": 0.272903890325686, "roe_period_end": 0.25328333680531445 } }, { "accn": "0001144204-19-041832", "filed": "2021-08-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 18548000.0, "cash": 29168000.0, "eps_diluted": 1.61, "free_cash_flow": 51460000.0, "gross_profit": 266879000.0, "net_income": 64883000.0, "operating_cash_flow": 70008000.0, "operating_income": 98926000.0, "stockholders_equity": 184954000.0, "total_assets": 671679000.0, "total_liabilities": 486725000.0 }, "period_end": "2018-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.6316002898017885, "roa_avg2y": 0.10019952496996315, "roa_period_end": 0.0965982262360443, "roe_avg2y": 0.3860807887870376, "roe_period_end": 0.3508061463931572 } }, { "accn": "0001144204-19-041832", "filed": "2020-08-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 20880000.0, "cash": 56083000.0, "eps_diluted": 1.61, "free_cash_flow": 77505000.0, "gross_profit": 248243000.0, "net_income": 64615000.0, "operating_cash_flow": 98385000.0, "operating_income": 97934000.0, "stockholders_equity": 151157000.0, "total_assets": 623397000.0, "total_liabilities": 472240000.0 }, "period_end": "2017-06-30", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.1241689104705705, "roa_avg2y": 0.10495991007381225, "roa_period_end": 0.1036498411124853, "roe_avg2y": 0.5348104801830845, "roe_period_end": 0.4274694522913262 } }, { "accn": "0001571049-17-007711", "filed": "2019-08-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 36352000.0, "cash": 33605000.0, "eps_diluted": 2.07, "free_cash_flow": 866000.0, "gross_profit": 239032000.0, "net_income": 82728000.0, "operating_cash_flow": 37218000.0, "operating_income": 85744000.0, "stockholders_equity": 90480000.0, "total_assets": 607835000.0, "total_liabilities": 517355000.0 }, "period_end": "2016-06-30", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 5.7178934571175954, "roa_period_end": 0.13610272524616054, "roe_period_end": 0.9143236074270557 } } ], "latest_filing": { "accn": "0001558370-25-011776", "filed": "2025-08-27", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001069899.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001069899.json" }, "ticker": "PAHC" }